Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655525 · ClinicalTrials.gov registry record · Phase 2
Omega-3 Fatty Acid Administration in Dialysis Patients
A Phase 2 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT00655525 is a Phase 2 study that has completed, run by Vanderbilt University. The registered enrollment target is 38 participants.
The verdict
NCT00655525, a Phase 2 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
The overall goal of this study is to examine the role of fish oil supplementation in ameliorating the inflammatory state of uremia and the related muscle protein catabolism associated with this disease state. We hypothesize that if administered for a period of 3 months, fish oil will improve the chronic uremic inflammation. We further hypothesize that fish oil administration will improve the muscle protein breakdown associated with uremia and inflammation.
Interventions
- DIETARY_SUPPLEMENT fish oil
- DIETARY_SUPPLEMENT placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655525
The ClinicalTrials.gov registry entry for NCT00655525 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fish oil is the first listed.
NCT00655525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655525 about?
NCT00655525 is a clinical study titled "Omega-3 Fatty Acid Administration in Dialysis Patients". The overall goal of this study is to examine the role of fish oil supplementation in ameliorating the inflammatory state of uremia and the related muscle protein catabolism associated with this disease state. We hypothesize that if administered for a period of 3 months, fish oil will improve the chr...
What is the current status of trial NCT00655525?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2008-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00655525?
The interventions under investigation include: fish oil (DIETARY_SUPPLEMENT), placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00655525?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.